- $2.48bn
- $2.05bn
- $2.12bn
Annual income statement for Privia Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 966 | 1,357 | 1,658 | 1,736 | 2,123 |
| Cost of Revenue | |||||
| Gross Profit | 63.7 | 135 | 162 | 177 | 209 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 1,184 | 1,376 | 1,637 | 1,719 | 2,089 |
| Operating Profit | -217 | -19.1 | 20.6 | 17 | 34.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -219 | -18.6 | 29 | 27.9 | 43.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -191 | -12.1 | 21 | 17 | 29.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -188 | -8.59 | 23.1 | 14.4 | 22.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -188 | -8.59 | 23.1 | 14.4 | 22.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.81 | -0.03 | 0.231 | 0.161 | 0.232 |